Prestige Biologics Co., Ltd. (KOSDAQ:334970)

Market Cap	195.94B -43.0%
Revenue (ttm)	19.24B +397.3%
Net Income	-28.23B
EPS	-343.91
Shares Out	77.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,214
Average Volume	133,173
Open	2,520.00
Previous Close	2,490.00
Day's Range	2,410.00 - 2,520.00
52-Week Range	2,300.00 - 5,220.00
Beta	0.75
RSI	41.15
Earnings Date	n/a

About Prestige Biologics

Prestige Biologics Co., Ltd. operates as a biopharmaceutical company in South Korea. The company offers budget finding, contract development, contract manufacturing, contract packaging, and analytical testing services. It also provides customized engineering solutions for manufacturing process under the ALITA Smart BioFactory brand name. Prestige Biologics Co., Ltd. was formerly known as PrestigeBio Pharmaceuticals and changed its name to Prestige Biologics Co., Ltd. in October 2019. The company was incorporated in 2015 and is based in Cheongju...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 334970

Financial Performance

In fiscal year 2025, Prestige Biologics's revenue was 12.53 billion, an increase of 477.83% compared to the previous year's 2.17 billion. Losses were -27.47 billion, -6.48% less than in 2024.